We, however, conclude that targeting ATM in SKOV3 is a potential important strategy in disrupting ovarian cancer proliferation, and overexpressing RYBP may offer new avenues for inhibiting ATM activity. The gene discussed is ATM; the disease is ovarian carcinoma.